Search Results - "Bertazzoni, A"
-
1
T.07.4: ACTIVE HCV OR HBV INFECTION DOES NOT IMPACT ON CLINICAL OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Published in Digestive and liver disease (01-04-2024)Get full text
Journal Article -
2
OC.16.6: APPLICATION OF MACHINE LEARNING MODEL-3P TO PREDICT PORTAL HYPERTENSION IN PATIENT WITH HEPATOCELLULAR CARCINOMA
Published in Digestive and liver disease (01-04-2024)Get full text
Journal Article -
3
Application of Machine Learning Model-3P to Predict Portal Hypertension in Patient with Hepatocellular Carcinoma
Published in Digestive and liver disease (01-02-2024)Get full text
Journal Article -
4
Clonidine-induced hyperglycemia: evidence against a growth hormone-mediated effect
Published in The Journal of pharmacology and experimental therapeutics (01-08-1980)“…The effects of acute clonidine infusion (0.15 mg over 10 min) on several endocrine and metabolic variables have been evaluated in 12 hypertensive patients and…”
Get more information
Journal Article -
5
Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia
Published in Metabolism, clinical and experimental (01-02-1977)“…The effect of 1-wk administration of clofibrate on plasma glucose and insulin (IRI) before and during oral glucose tolerance tests (OGTT), as well as on serum…”
Get more information
Journal Article -
6
Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects
Published in Metabolism, clinical and experimental (01-10-1978)“…Metergoline (4 mg) and methysergide (3 mg), two serotonin antagonists known to inhibit prolactin secretion in normal subjects, and the dopaminergic agonist,…”
Get more information
Journal Article -
7
Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma
Published in Fertility and sterility (01-08-1978)“…A patient with amenorrhea due to a prolactin-secreting pituitary microadenoma was treated with the antiserotoninergic drug metergoline for 8 months. The first…”
Get more information
Journal Article -
8
Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes
Published in Hormone and metabolic research (01-01-1978)“…Following seven days clofibrate administration, the glucose disappearance rate during an intravenous glucose tolerance test was significantly increased in 6…”
Get more information
Journal Article -
9
Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus
Published in Biomedicine / [publiee pour l'A.A.I.C.I.G.] (01-06-1978)“…The effect of 1 week clofibrate administration on glucose and insulin responses to oral glucose and to intravenous tolbutamide was evaluated in 21 patients…”
Get more information
Journal Article -
10
Endocrine and metabolic effects of labetalol in man
Published in Journal of cardiovascular pharmacology (01-09-1981)“…The effects of intravenous infusion of the alpha- and beta-adrenoceptor blocking drug labetalol (100 mg over 10 min) on heart rate, blood pressure, and several…”
Get more information
Journal Article -
11
Letter: Reduction of serum alkaline phosphatase and gamma-glutamyl transpeptidase activities by short-term clofibrate
Published in The New England journal of medicine (19-08-1976)Get more information
Journal Article -
12
Potentiation of hypoglycemic response to intravenous tolbutamide by clofibrate
Published in The New England journal of medicine (20-05-1976)Get more information
Journal Article -
13
Report on 6-month use of the Coulter Counter, model S
Published in Annali dell'Istituto superiore di sanità (1971)Get more information
Journal Article -
14